Sort by
Refine Your Search
-
Listed
-
Program
-
Employer
- University of Antwerp
- Ghent University
- KU Leuven
- VIB
- IMEC
- Hasselt University
- Vrije Universiteit Brussel
- UCLouvain
- FNRS - WELBIO
- Free University of Brussels
- IRIBHM-Université Libre de Bruxelles
- KU Leuven (Coordinator)
- Siemens
- University of Liege
- Université Libre de Bruxelles (ULB)
- Vrije Universiteit Brussel (VUB)
- 6 more »
- « less
-
Field
-
specifically focus on extending NicheNet, the Cell-Cell Communication Inference tool developed by the Saeys lab, for spatial omics data. You will collaborate closely with renowned groups, including the Martin
-
reporting about the techno-economic analysis (TEA) and life cycle analysis (LCA) of the upscaling of the manufacturing of flexible perovskite solar cells. The goal being to evaluate and stimulate
-
of proteomics and auditory neuroscience. This 3-year scholarship is focused on the identification of proteins important in the functional cochlea generally, and the hair cells in the organ of Corti more
-
Research Infrastructure? No Offer Description Join an international and multidisciplinary research team to explore and manipulate three-atom-thin semiconductors at the forefront of semiconductor technology
-
variety of therapeutic targets. Specifically, the project will aim to develop innovative genome-editing solutions for gene therapy on autologous hematopoietic stem cells Gene therapy using autologous
-
student will be employed at the University of Bern and one at the KU Leuven according to the guidelines of the respective universities. The appointment is initially for the duration of 1 year (starting date
-
develop and apply low-dose TEM techniques such as exit wave reconstruction and integrated differential phase contrast imaging to investigate CsPbI3 thin films without electron beam damage. You will expand
-
of the largest, most international and most innovative employers in the region. With more than 6000 employees from 100 different countries, we are helping to build tomorrow's world every day. Through top
-
in plants and we combine cell biological and biochemical/structural approaches to answer our research questions. We are highly passionate about the endocytic pathway that controls the plasma membrane
-
, lethal, hard-to-cure brain tumor. Accumulating evidence points to extensive tumor heterogeneity, as well as plasticity in response to therapy, leading to therapy failure. At the single cell level, this